SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-23-000003
Filing Date
2023-05-10
Accepted
2023-05-10 06:36:02
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20230331.htm   iXBRL 10-Q 1469793
2 EX-31.1 ex311_2023-03.htm EX-31.1 11304
3 EX-31.2 ex312_2023-03.htm EX-31.2 13078
4 EX-32.1 ex321_2023-03.htm EX-32.1 9874
  Complete submission text file 0001590750-23-000003.txt   6784145

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20230331.xsd EX-101.SCH 43588
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20230331_cal.xml EX-101.CAL 55609
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20230331_def.xml EX-101.DEF 257315
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20230331_lab.xml EX-101.LAB 595160
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20230331_pre.xml EX-101.PRE 380216
57 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20230331_htm.xml XML 1015376
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 23904233
SIC: 8071 Services-Medical Laboratories